glioblastoma multiforme

Latest

glioblastoma multiforme

Brain Cancer Featured Genetics Neurology Neuroscience

·January 11, 2019·6 min read

A Patient’s Sex Matters When it Comes to Brain Cancer

Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.

Brain Cancer Featured Genetics Neurology Open Neuroscience Articles

·January 2, 2019·7 min read

Sex Differences Identified in Glioblastoma Brain Cancer

A new study reveals distinct molecular differences in signatures of glioblastoma brain cancer between men and women. Researchers report current treatments for the brain cancer are more effective in women than in men. The findings could help to tailor treatments aimed at the different sexes and improve survival.

Brain Cancer Featured Neurology Open Neuroscience Articles

·November 19, 2018·3 min read

Drug Discovery Could Halt Brain Cancer Spread

Researchers detail the use of a drug that may help block the way glioblastoma brain cancer cells respond to fluid flow. The finding could lead to stopping glioblastoma from spreading.

Brain Cancer Featured Neurology Open Neuroscience Articles

·June 27, 2018·7 min read

Poliovirus Therapy for Recurrent Glioblastoma Has 3 Year Survival Rate of 21%

A new study reports a genetically modified poliovirus therapy has been shown to improve long term survival rates in recurrent glioblastoma brain cancer patients. Researchers say the therapy had a three year survival rate for 21 percent of participants in a phase 1 clinical trial, compared to just 4% of patients who received more standard treatments.

Brain Cancer Featured Genetics Neurology

·June 6, 2018·4 min read

Brain Cancer Atlas Created

A new brain cancer atlas maps out comprehensive, visually rich information about the anatomical and genetic bases of glioblastoma, researchers report.

a brain slice from a patient with glioblastoma brain cancer

Brain Cancer Featured Genetics Neurology

·June 4, 2018·5 min read

A Potential Achilles Heel in Brain Cancer

A new study in PNAS reports blocking the expression of MDA-9/Syntenin forces glioma stem cells to lose their ability to induce protective autophagy.

Brain Cancer Featured Neurology Open Neuroscience Articles

·May 24, 2018·5 min read

Tiny Particles Could Help Fight Brain Cancer

Researchers at MIT have developed a new drug delivering nanoparticle that is able to cross the blood-brain barrier. The nanoparticles carry two different drugs that can help shrink tumors and prevent them from growing back.

Brain Cancer Featured Genetics Neurology Open Neuroscience Articles

·April 25, 2018·4 min read

Organoids Reveal how Deadly Brain Cancers Grow

Researchers use gene editing to generate aggressive glioblastoma multiforme brain tumors in the lab. The model, researchers say, could be used to track the progression of tumors and develop personalized therapies for patients.

Brain Cancer Featured Neurology Open Neuroscience Articles

·February 9, 2018·6 min read

Genes Associated With Glioblastoma Brain Cancer Identified

A new study describes glioblastoma specific gene co-expression relationships between a group of 22 genes.

Brain Cancer Featured

·January 23, 2018·6 min read

Blocking the Siren Call of Two Aggressive Cancers

An inhibitor of the 20-HETE chemical has been used to successfully control the spread and growth of human glioblastoma and breast cancer in lab models of the diseases, researchers report.

Brain Cancer Featured Neurology

·January 22, 2018·5 min read

Combination Chemotherapy May Significantly Improve Treatment for Glioblastoma

Researchers report the addition of an FDA approved chemotherapy drug called hydroxyyurea to temozolomide helps to increase survival rates in animal models of glioblastoma.

Brain Cancer Featured Neurology

·November 27, 2017·7 min read

Cancer Drug Starts Clinical Trials in Human Brain Cancer Patients

A new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers.

1 2 3 4 5 6